Investor Relations

A leadership story in the field of advanced cell therapy

Investor Relations

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Aastrom Biosciences to Hold Investor Conference Call
Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, January 30, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will hold an investor conference call on Wednesday, February 4, 2004 at 11:00 a.m. EST. The call is intended to bring shareholders and
View HTML
Toggle Summary Aastrom Biosciences Announces Initiation of Bone Graft Clinical Study in Germany
Bergmannsheil University Begins Patient Enrollment for New Stem Cell Treatment of Severe Leg Fractures
View HTML
Toggle Summary Aastrom Biosciences Announces Initiation of Bone Graft Clinical Study in Germany
-- Bergmannsheil University Begins Patient Enrollment for New Stem Cell Treatment of Severe Leg Fractures --
View HTML
Toggle Summary Aastrom Biosciences Initiates Bone Graft Clinical Trial at Lead U.S. Site
Evaluation of Stem Cell Product for Leg Fracture Healing Begins in Chicago
View HTML
Toggle Summary Aastrom Biosciences Initiates Bone Graft Clinical Trial at Lead U.S. Site
-- Evaluation of Stem Cell Product for Leg Fracture Healing Begins in Chicago --
View HTML
Toggle Summary Aastrom's Dendritic Cell Vaccine Technology to be Utilized in Duke University's Clinical Trial for New Cancer Treatment
-- Duke Clinical Trial Seeks New Treatment for GI Tract Cancers --
View HTML
Toggle Summary Aastrom Biosciences Holds Investor Conference Call Today
Aastrom Biosciences Holds Investor Conference Call Today Ann Arbor, Michigan, November 14, 2003 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) will hold an investor call today, November 14, 2003 at 10:00 a.m. EST. The purpose of the call is to bring shareholders and other interested parties
View HTML
Toggle Summary Aastrom Biosciences to Hold Investor Conference Call
Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, November 12, 2003 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that it will hold an investor conference call on Friday, November 14, 2003 at 10:00 a.m. EST. The purpose of the call will be to bring
View HTML
Toggle Summary Aastrom Biosciences, Inc. Reports First Quarter 2004 Financial Results
-- Company Prepares to Enter Clinical Trials of Bone Graft Product --
View HTML
Toggle Summary Aastrom Biosciences Launches Direct Stock Purchase Program
-- Program Offers Shareholders Exclusive Investment Opportunity --
View HTML

Day High:
Day Low:
Volume:
on
Copyright West LLC. Minimum 15 minutes delayed.